These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2965694)

  • 1. Protease-inhibitory activities of leupeptin analogues.
    Saino T; Someno T; Ishii S; Aoyagi T; Umezawa H
    J Antibiot (Tokyo); 1988 Feb; 41(2):220-5. PubMed ID: 2965694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New leupeptin analogues: synthesis and inhibition data.
    McConnell RM; Barnes GE; Hoyng CF; Gunn JM
    J Med Chem; 1990 Jan; 33(1):86-93. PubMed ID: 2136920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition studies of some serine and thiol proteinases by new leupeptin analogues.
    McConnell RM; York JL; Frizzell D; Ezell C
    J Med Chem; 1993 Apr; 36(8):1084-9. PubMed ID: 8478905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of leupeptins and inhibition of proteinases. I. Inhibition of acrosin and trypsin.
    Borin G; Chessa G; Cavaggion G; Marchiori F; Müller-Esterl W
    Hoppe Seylers Z Physiol Chem; 1981 Nov; 362(11):1435-45. PubMed ID: 7030914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reaction of a tumour-associated trypsin inhibitor with serine proteinases associated with coagulation and tumour invasion.
    Turpeinen U; Koivunen E; Stenman UH
    Biochem J; 1988 Sep; 254(3):911-4. PubMed ID: 2461702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino acids and peptides. LIII. Synthesis and biological activities of some pseudo-peptide analogs of PKSI-527, a plasma kallikrein selective inhibitor: the importance of the peptide backbone.
    Fukumizu A; Tsuda Y; Wanaka K; Tada M; Okamoto S; Hijikata-Okunomiya A; Okada Y
    Chem Pharm Bull (Tokyo); 1999 Aug; 47(8):1141-4. PubMed ID: 10478469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aromatic amidines: comparison of their ability to block respiratory syncytial virus induced cell fusion and to inhibit plasmin, urokinase, thrombin, and trypsin.
    Tidwell RR; Geratz JD; Dubovi EJ
    J Med Chem; 1983 Feb; 26(2):294-8. PubMed ID: 6219223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic inhibitors of trypsin, plasmin, kallikrein, thrombin, C1r-, and C1 esterase.
    Tamura Y; Hirado M; Okamura K; Minato Y; Fujii S
    Biochim Biophys Acta; 1977 Oct; 484(2):417-22. PubMed ID: 143965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tripeptides with non-code amino acids as potential serine proteases inhibitors.
    Markowska A; Bruzgo M; Surażyński A; Midura-Nowaczek K
    J Enzyme Inhib Med Chem; 2013 Jun; 28(3):639-43. PubMed ID: 22299583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of netropsin and pentamidine amino analogues on the amidolytic activity of plasmin, trypsin and urokinase.
    Pućkowska A; Midura-Nowaczek K; Bruzgo I
    Acta Pol Pharm; 2008; 65(2):213-5. PubMed ID: 18666427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affinity chromatography of urokinase on an agarose derivative coupled with pyroglutamyl-lysyl-leucyl-argininal.
    Someno T; Saino T; Katoh K; Miyazaki H; Ishii S
    J Biochem; 1985 May; 97(5):1493-500. PubMed ID: 4030734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological activities of leupeptins.
    Aoyagi T; Miyata S; Nanbo M; Kojima F; Matsuzaki M
    J Antibiot (Tokyo); 1969 Nov; 22(11):558-68. PubMed ID: 4243683
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of plasma kallikrein selective inhibitors.
    Okada Y; Tsuda Y; Tada M; Wanaka K; Hijikata-Okunomiya A; Okamoto U; Okamoto S
    Biopolymers; 1999; 51(1):41-50. PubMed ID: 10380351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The irreversible inhibition of urokinase, kidney-cell plasminogen activator, plasmin and beta-trypsin by 1-(N-6-amino-n-hexyl)carbamoylimidazole.
    Walker B; Elmore DT
    Biochem J; 1984 Jul; 221(1):277-80. PubMed ID: 6235806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of fibrinolytic enzymes by thrombin inhibitors.
    Gilboa N; Villannueva GB; Fenton JW
    Enzyme; 1988; 40(2-3):144-8. PubMed ID: 2971531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of omega-guanidino acid esters on trypsin, plasmin, thrombin and plasma kallikrein.
    Muramatu M; Fujii S
    J Biochem; 1968 Dec; 64(6):807-14. PubMed ID: 4238018
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies of kallikrein inhibitors in potatoes. II. Effect of potato kallikrein inhibitors on various kallikreins and other proteases.
    Hojima Y; Moriya H; Moriwaki C
    J Biochem; 1971 Jun; 69(6):1027-32. PubMed ID: 4253726
    [No Abstract]   [Full Text] [Related]  

  • 18. Suppression of in vitro invasion of human fibrosarcoma cells by a leupeptin analogue inhibiting the urokinase-plasmin system.
    Kawada M; Umezawa K
    Biochem Biophys Res Commun; 1995 Apr; 209(1):25-30. PubMed ID: 7726842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of trypsin-like serine proteinases by tripeptide arginyl and lysyl chloromethylketones.
    Lijnen HR; Uytterhoeven M; Collen D
    Thromb Res; 1984 Jun; 34(5):431-7. PubMed ID: 6234678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New synthetic inhibitors of C1r, C1 esterase, thrombin, plasmin, kallikrein and trypsin.
    Fujii S; Hitomi Y
    Biochim Biophys Acta; 1981 Oct; 661(2):342-5. PubMed ID: 6271224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.